Navigation Links
IRIDEX Reports 2014 Second Quarter, Six-Month Results
Date:7/31/2014

evidence that MicroPulse® is becoming more accepted as a leading treatment for diabetes-related retinal disease. The therapeutic benefits to patients are well documented and the advantageous economic benefits of MicroPulse as compared to drugs and other treatment modalities to health care systems are becoming more obvious."

2Q 2014 Business Highlights

  • Data from a one-year, multi-center study demonstrating the safety and durability of MicroPulse technology as a treatment for glaucoma was presented at the American Society of Cataract and Refractive Surgeons (ASCRS) conference in April.
  • More than 300 ophthalmologists attended a symposium led by Drs. Ike Ahmed, David Gossage and Elias Reichel on the versatility of MicroPulse as a treatment option for various retinal diseases and as a treatment option for glaucoma at ASCRS.
  • Share Repurchase Program
    As of last week, the company has satisfied its share repurchase program established in February, 2013, buying approximately 377,000 shares at an average price of $7.97.  Effective today, the IRIDEX Board of Directors established a new share repurchase program, allowing the purchase of up to $3.0 million worth of the company's common stock over the next 12 months.

    Conference Call
    IRIDEX management will conduct a conference call later today, Thursday, July 31, 2014, at 5:00 pm Eastern Time.  Interested parties may access the live conference call by dialing (877) 407-0784 (US) or (201) 689-8560 (International) and requesting the IRIDEX Second Quarter 2014 Earnings Conference Call, or by visiting the company's website at www.iridex.com.  A telephone replay will be available beginning on Thursday, July 31, 2014 through Thursday, August 7, 2014 by dialing (877) 870-5176 (US) or (858) 384-5517 (International) and entering Replay Pin # 13586659.  In addition, later today an archived version of the webcast will be
    '/>"/>

    SOURCE IRIDEX
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. IRIDEX Announces Second Quarter 2014 Conference Call and Release Date
    2. IRIDEX To Introduce Four New Products At Annual AAO Meeting
    3. IRIDEX Promotes Timothy D. Buckley to Vice President of Marketing and North American Sales
    4. IRIDEX Reports 2013 Third Quarter Results
    5. IRIDEX Announces Third Quarter 2013 Conference Call and Release Date
    6. IRIDEX to Present at Craig-Hallum 4th Annual Alpha Select Conference
    7. IRIDEX to Present at 2013 Wedbush Securities Life Sciences Management Access Conference
    8. IRIDEX Reports 2013 Second Quarter Results; $9.2 Million Record Q2 Revenue
    9. IRIDEX Announces Second Quarter 2013 Conference Call and Release Date
    10. IRIDEX Announces Automatic Conversion of Series A Preferred Stock to Common Stock
    11. IRIDEX Receives Final $510,000 From Sale Of Aesthetic Business Unit
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/1/2015)... 1, 2015  An innovative interventional radiology treatment ... sustained relief of their headaches, according to research ... Radiology ,s Annual Scientific Meeting . Clinicians ... New York Empire State College in Saratoga Springs ... (SPG) blocks to give patients enough ongoing relief ...
    (Date:3/1/2015)... 2015  USPlabs has notified the Food and ... that media reports saying that a company product ... February 28, 2015, the Center for Drug Evaluation ... the contamination of a dietary supplement product labeled ... as "OEP") with a prescription drug active ingredient, ...
    (Date:2/27/2015)... CHAPEL HILL, N.C. , Feb. 27, 2015 /PRNewswire/ ... the challenge of managing multiple products for the same ... especially for those that want to prevent one of ... of another.  According to recent research by ... promoted their products as independent brands rather than together ...
    Breaking Medicine Technology:Image-guided treatment shown to break the migraine cycle 2Image-guided treatment shown to break the migraine cycle 3Image-guided treatment shown to break the migraine cycle 4OEP Product Is Counterfeit 2New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2
    ... 28, 2011 Hotspur Technologies announced today that ... first clinical use of its Keeper™ Embolectomy Catheter. ... formation within arteries, while also incorporating the capability ... catheter. The Keeper Catheter combines a ...
    ... ShangPharma Corporation (NYSE: SHP ) ("ShangPharma" or ... and development outsourcing company, today announced that it will ... in New York from March 1 – 3, 2011. ... ShangPharma, will host a group presentation at 10:00 am ...
    Cached Medicine Technology:Hotspur's Keeper Embolectomy Catheter Deployed for First Time 2ShangPharma to Present at the Citibank Global Health Care Conference from March 1 - 3, 2011 2
    (Date:3/1/2015)... 02, 2015 Security Life Insurance ... benefits market, announced the addition of stand-alone individual ... Vision Insurance launched today, complete with two plan ... utilize the VSP® Vision Care network encompassing a ... practice space. The PrimeStar Select Vision plan will ...
    (Date:3/1/2015)... 2015 Women’s Excellence now offers ... (OAB) symptoms, such as a strong need to urinate with ... medication (anticholinergic) does not work well enough or cannot be ... another approach to targeting the source of OAB, the bladder ... and bladder muscle, blocking the signals that trigger OAB. ...
    (Date:3/1/2015)... March 01, 2015 Researchers say working ... so many sheet metal workers contract malignant mesothelioma. Surviving ... report on its website. Click here to read ... Construction Research and Training monitored 17,345 sheet metal workers ... number of them died of mesothelioma or another ...
    (Date:3/1/2015)... New York, NY (PRWEB) March 01, 2015 ... ) has grown substantially over the past few weeks ... Liebhard LLP are actively filing claims, the Firm announces. ... 2015 reflects 7,713 cases in the Bergen County proceeding ... Ethicon Inc., compared with a few weeks earlier, when ...
    (Date:3/1/2015)... 2015 “ The Barrel Mill ” was ... which takes a look at the latest and coolest technology ... of NewsWatch and a technology expert, conducted the review and ... to drinks. , According to Home Distillation of Alcohol, it's ... Well, there’s a pretty cool product that’ll help anyone achieve ...
    Breaking Medicine News(10 mins):Health News:Security Life Insurance Company Launches Individual Vision Insurance Product 2Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2Health News:New Study Finds Indirect Asbestos Exposure Can Raise Mesothelioma Risk for Sheet Metal Workers, According to Surviving Mesothelioma 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4Health News:An Oak Infusion Spiral was Featured on NewsWatch Television on January 30, 2015 2
    ... ... PhD, JD, is Keynote Speaker on the Failed War on Drugs , ... Las Vegas, NV (PRWEB) September 11, 2009 -- ... Drug Policy Alliance advocating for drug reform in the United States as keynote speaker former ...
    ... acoustic neuromas , FRIDAY, Sept. 11 (HealthDay News) -- Last ... or the sound of a dog barking. She was 22. ... type 2 (NF2), a condition characterized by tumors in the ... cranial nerve in one ear. , The result: increasing hearing ...
    ... affects insulin resistance, study finds, , FRIDAY, Sept. 11 (HealthDay ... insight into type 2 diabetes, potentially leading to better treatment ... appears to be linked to diabetes, affects how the body ... published Sept. 6 in Nature Genetics . , "Most ...
    ... Duane Reade Holdings Inc., the largest drug store in metropolitan New ... 2009 Komen New York City Race For The Cure, the Company, ... raised $330,000 to increase awareness of breast cancer and to assist ... year that Duane Reade has proudly sponsored this momentous event, with ...
    ... , , MADISON, N.J. and ... (FDA) today cleared the OVA1(TM) Test, the first blood test that, ... at risk for a malignant pelvic mass. OVA1 is the first ... with high sensitivity prior to biopsy or exploratory surgery, even if ...
    ... , , , ... Gardasil, declined by a third this year, and three years after ... women remain unvaccinated -- despite millions spent on advertising and lobbying ... , , Michelle Steward, assistant professor of marketing ...
    Cached Medicine News:Health News:Healthcare Legal Issues Take the Stage at PAINWeek 2009 2Health News:Healthcare Legal Issues Take the Stage at PAINWeek 2009 3Health News:Cancer Drug Shrinks Benign Tumors That Steal Hearing 2Health News:Cancer Drug Shrinks Benign Tumors That Steal Hearing 3Health News:New Yorkers Help Duane Reade Increase Support of the 19th Annual Komen New York City Race For The Cure(R) 2Health News:New Yorkers Help Duane Reade Increase Support of the 19th Annual Komen New York City Race For The Cure(R) 3Health News:U.S. Food and Drug Administration Clears Vermillion's OVA1(TM) Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 2Health News:U.S. Food and Drug Administration Clears Vermillion's OVA1(TM) Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 3Health News:U.S. Food and Drug Administration Clears Vermillion's OVA1(TM) Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 4Health News:U.S. Food and Drug Administration Clears Vermillion's OVA1(TM) Test to Determine Likelihood of Ovarian Cancer in Women with Pelvic Mass 5Health News:HPV Vaccine Study Shows Why Few Women Getting Shots 2
    ... test for the presence of blood is based ... guaiac to quinones, resulting in the production of ... heme portion of the hemoglobin molecule can function ... oxygen from hydrogen peroxide which in turn causes ...
    ... elitewas designed to improve patient compliance. Its ... sample collection options make this fecal occult ... and complete. Diet guidelines are explained in ... which foods and drugs are okay and ...
    ... The Original MaybeMom™ Mini ... medical diagnostic instument which uses ... her personal menstrual/fertility cycle, including ... ovulation and menstruation to increase ...
    ... The scientific principles supporting the effectiveness ... established, based upon extensive clinical studies. As ... cycle her estrogen level increases, thereby, elevating ... fluids such as saliva is allowed to ...
    Medicine Products: